CRYO-CELL INTERNATIONAL, INC. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period
CRYO-CELL INTERNATIONAL, INC. (CCEL) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period of 50.55 thousand shares for the 9-month period ending 2018-08-31, per its 10-Q filed 2018-10-15.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod · last filed 2018-10-15
- CRYO-CELL INTERNATIONAL, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for the quarter ending 2018-08-31 was 8.75K shares, a 10.61% decline year-over-year.
- CRYO-CELL INTERNATIONAL, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for the quarter ending 2018-05-31 was 22.84K shares, a 306.04% increase year-over-year.
- CRYO-CELL INTERNATIONAL, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for the quarter ending 2018-02-28 was 18.96K shares, a 0.00% change year-over-year.
- CRYO-CELL INTERNATIONAL, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for the quarter ending 2017-11-30 was 48.86K shares, a 0.00% change year-over-year.
- CRYO-CELL INTERNATIONAL, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for fiscal 2017 was 83.24K shares, a 31.95% decline from fiscal 2016.
- CRYO-CELL INTERNATIONAL, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for fiscal 2016 was 122.33K shares, a 253.75% increase from fiscal 2015.
- CRYO-CELL INTERNATIONAL, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for fiscal 2015 was 34.58K shares, a 54.14% decline from fiscal 2014.
- CRYO-CELL INTERNATIONAL, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for fiscal 2014 was 75.41K shares, a 48.26% decline from fiscal 2013.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 12 month |
|---|---|---|---|---|
| 2018-08-31 | 8.75K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-15 | 31.59K shares derived: sum of 2 quarters · filed 2018-10-15 | 50.55K shares 10-Q · filed 2018-10-15 | 99.41K shares derived: sum of 4 quarters · filed 2018-10-15 |
| 2018-05-31 | 22.84K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-16 | 41.80K shares 10-Q · filed 2018-07-16 | 90.66K shares derived: sum of 3 quarters · filed 2018-07-16 | 100.45K shares derived: sum of 4 quarters · filed 2018-07-16 |
| 2018-02-28 | 18.96K shares 10-Q · filed 2018-04-16 | 67.82K shares derived: sum of 2 quarters · filed 2018-04-16 | 77.61K shares derived: sum of 3 quarters · filed 2018-04-16 | 83.24K shares derived: sum of 4 quarters · filed 2018-04-16 |
| 2017-11-30 | 48.86K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | 58.66K shares derived: sum of 2 quarters · filed 2018-02-28 | 64.28K shares derived: sum of 3 quarters · filed 2018-02-28 | 83.24K shares 10-K · filed 2018-02-28 |
| 2017-08-31 | 9.79K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-16 | 15.42K shares derived: sum of 2 quarters · filed 2017-10-16 | 34.37K shares 10-Q · filed 2017-10-16 | 83.24K shares derived: sum of 4 quarters · filed 2017-10-16 |
| 2017-05-31 | 5.63K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-07 | 24.58K shares 10-Q · filed 2017-07-07 | 73.45K shares derived: sum of 3 quarters · filed 2017-07-07 | 79.07K shares derived: sum of 4 quarters · filed 2017-07-07 |
| 2017-02-28 | 18.96K shares 10-Q · filed 2017-04-13 | 67.82K shares derived: sum of 2 quarters · filed 2017-04-13 | 73.45K shares derived: sum of 3 quarters · filed 2017-04-13 | 135.66K shares derived: sum of 4 quarters · filed 2017-04-13 |
| 2016-11-30 | 48.86K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | 54.49K shares derived: sum of 2 quarters · filed 2017-02-28 | 116.70K shares derived: sum of 3 quarters · filed 2017-02-28 | 122.33K shares 10-K · filed 2017-02-28 |
| 2016-08-31 | 5.63K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-17 | 67.84K shares derived: sum of 2 quarters · filed 2016-10-17 | 73.46K shares 10-Q · filed 2016-10-17 | 80.97K shares derived: sum of 4 quarters · filed 2016-10-17 |
| 2016-05-31 | 62.21K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-11 | 67.84K shares 10-Q · filed 2016-07-11 | 75.34K shares derived: sum of 3 quarters · filed 2016-07-11 | 83.67K shares derived: sum of 4 quarters · filed 2016-07-11 |
| 2016-02-29 | 5.63K shares 10-Q · filed 2016-04-14 | 13.13K shares derived: sum of 2 quarters · filed 2016-04-14 | 21.46K shares derived: sum of 3 quarters · filed 2016-04-14 | 28.75K shares derived: sum of 4 quarters · filed 2016-04-14 |
| 2015-11-30 | 7.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | 15.83K shares derived: sum of 2 quarters · filed 2016-02-29 | 23.12K shares derived: sum of 3 quarters · filed 2016-02-29 | 34.58K shares 10-K · filed 2016-02-29 |
| 2015-08-31 | 8.33K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-15 | 15.62K shares derived: sum of 2 quarters · filed 2015-10-15 | 27.08K shares 10-Q · filed 2015-10-15 | 32.49K shares derived: sum of 4 quarters · filed 2015-10-15 |
| 2015-05-31 | 7.29K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-15 | 18.75K shares 10-Q · filed 2015-07-15 | 24.16K shares derived: sum of 3 quarters · filed 2015-07-15 | 50.41K shares derived: sum of 4 quarters · filed 2015-07-15 |
| 2015-02-28 | 11.46K shares 10-Q · filed 2015-04-14 | 16.87K shares derived: sum of 2 quarters · filed 2015-04-14 | 43.12K shares derived: sum of 3 quarters · filed 2015-04-14 | 67.91K shares derived: sum of 4 quarters · filed 2015-04-14 |
| 2014-11-30 | 5.41K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | 31.67K shares derived: sum of 2 quarters · filed 2015-03-02 | 56.45K shares derived: sum of 3 quarters · filed 2015-03-02 | 75.41K shares 10-K · filed 2015-03-02 |
| 2014-08-31 | 26.25K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-15 | 51.04K shares derived: sum of 2 quarters · filed 2014-10-15 | 70.00K shares 10-Q · filed 2014-10-15 | 83.96K shares derived: sum of 4 quarters · filed 2014-10-15 |
| 2014-05-31 | 24.79K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-03 | 43.74K shares 10-Q · filed 2014-07-03 | 57.70K shares derived: sum of 3 quarters · filed 2014-07-03 | 105.41K shares derived: sum of 4 quarters · filed 2014-07-03 |
| 2014-02-28 | 18.95K shares 10-Q · filed 2014-04-14 | 32.92K shares derived: sum of 2 quarters · filed 2014-04-14 | 80.62K shares derived: sum of 3 quarters · filed 2014-04-14 | 115.62K shares derived: sum of 4 quarters · filed 2014-04-14 |
| 2013-11-30 | 13.96K shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | 61.66K shares derived: sum of 2 quarters · filed 2014-02-28 | 96.67K shares derived: sum of 3 quarters · filed 2014-02-28 | 145.76K shares 10-K · filed 2014-02-28 |
| 2013-08-31 | 47.70K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-15 | 82.70K shares derived: sum of 2 quarters · filed 2013-10-15 | 131.79K shares 10-Q · filed 2013-10-15 | 259.21K shares derived: sum of 4 quarters · filed 2013-10-15 |
| 2013-05-31 | 35.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-15 | 84.09K shares 10-Q · filed 2013-07-15 | 211.50K shares derived: sum of 3 quarters · filed 2013-07-15 | |
| 2013-02-28 | 49.09K shares 10-Q · filed 2013-04-15 | 176.50K shares derived: sum of 2 quarters · filed 2013-04-15 | ||
| 2012-11-30 | 127.41K shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | 765.49K shares 10-K · filed 2013-02-28 | ||
| 2012-08-31 | 638.07K shares 10-Q · filed 2012-10-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |